<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Bullfrog Ai Holdings, Inc. Common Stock — News on 6ix</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock</link>
<description>Latest news and press releases for Bullfrog Ai Holdings, Inc. Common Stock on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/bullfrog-ai-holdings-inc-common-stock" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354c5678dffbe2df0e5794.webp</url>
<title>Bullfrog Ai Holdings, Inc. Common Stock</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock</link>
</image>
<item>
<title>BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-regains-compliance-with-nasdaq-shareholders-equity-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-regains-compliance-with-nasdaq-shareholders-equity-requirement</guid>
<pubDate>Wed, 22 Apr 2026 11:30:00 GMT</pubDate>
<description>Strengthened balance sheet provides capital runway into late 2027GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has regained compliance with the minim</description>
</item>
<item>
<title>BullFrog AI Announces Participation at AACR Annual Meeting</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-participation-at-aacr-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-participation-at-aacr-annual-meeting</guid>
<pubDate>Tue, 14 Apr 2026 11:30:00 GMT</pubDate>
<description>BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957GAITHERSBURG, Md., April 14, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual</description>
</item>
<item>
<title>BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-provides-business-update-strengthened-balance-sheet-supports-continued-execution-as-company-aims-to-ramp-commercial-activity-with-global-pharmaceutical-and-biotechnology-partners</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-provides-business-update-strengthened-balance-sheet-supports-continued-execution-as-company-aims-to-ramp-commercial-activity-with-global-pharmaceutical-and-biotechnology-partners</guid>
<pubDate>Mon, 13 Apr 2026 04:00:00 GMT</pubDate>
<description>First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027</description>
</item>
<item>
<title>BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-commercial-agreement-with-top-5-global-pharmaceutical-company-to-identify-and-prioritize-therapeutic-target-in-major-depressive-disorder</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-commercial-agreement-with-top-5-global-pharmaceutical-company-to-identify-and-prioritize-therapeutic-target-in-major-depressive-disorder</guid>
<pubDate>Mon, 30 Mar 2026 04:00:00 GMT</pubDate>
<description>Commercial agreement serves as high-profile third party validation of BullFrog AI’s proprietary capabilities Agreement utilizes BullFrog AI’s end-to-end</description>
</item>
<item>
<title>BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-unveils-bfarenastm-scenario-based-decision-engine</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-unveils-bfarenastm-scenario-based-decision-engine</guid>
<pubDate>Wed, 25 Mar 2026 04:00:00 GMT</pubDate>
<description>Completes end-to-end AI intelligence workflow product with an advanced AI decision tool that clearly defines drug target discovery and clinical trial</description>
</item>
<item>
<title>BullFrog to Host Webinar on New Precision AI Capability</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-to-host-webinar-on-new-precision-ai-capability</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-to-host-webinar-on-new-precision-ai-capability</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>March 27 webinar at 11 a.m. ET highlights launch of BullFrog AI’s new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial</description>
</item>
<item>
<title>BullFrog AI to Unveil New Precision AI Capability</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-unveil-precision-ai-123000247</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-unveil-precision-ai-123000247</guid>
<pubDate>Wed, 04 Feb 2026 12:30:00 GMT</pubDate>
<description>New capabilities to be launched on March 25Unique technology bolsters BullFrog AI’s end-to-end AI intelligence workflow with a scenario-based decision engineAdvances current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios GAITHERSBURG, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine l</description>
</item>
<item>
<title>BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-data-harmonization-hidden-123000053</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-data-harmonization-hidden-123000053</guid>
<pubDate>Tue, 27 Jan 2026 12:30:00 GMT</pubDate>
<description>White paper discusses how BullFrog AI’s bfPREP™ embodies data harmonization, enabling biopharma organizations to convert noisy, document-heavy data into standardized, AI-ready datasetsGAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmo</description>
</item>
<item>
<title>BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-driven-precision-oncology-123000118</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-driven-precision-oncology-123000118</guid>
<pubDate>Tue, 06 Jan 2026 12:30:00 GMT</pubDate>
<description>Company’s bfLEAP® platform successfully identified treatment effect heterogeneity and possible early predictors of outcomes in pancreatic cancer in data to...</description>
</item>
<item>
<title>BullFrog AI Publishes Annual Letter to Shareholders</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-publishes-annual-letter-130000921</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-publishes-annual-letter-130000921</guid>
<pubDate>Tue, 30 Dec 2025 13:00:00 GMT</pubDate>
<description>Highlights significant progress in 2025 and outlines commercial priorities and potential catalysts entering 2026GAITHERSBURG, Md., Dec. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the release of its annual letter to shareholders, which highl</description>
</item>
<item>
<title>BullFrog AI and Myriad Uranium Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-and-myriad-uranium-interviews-to-air-on-the-redchip-small-stocks-big-moneytm-show-on-bloomberg-tv</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-and-myriad-uranium-interviews-to-air-on-the-redchip-small-stocks-big-moneytm-show-on-bloomberg-tv</guid>
<pubDate>Fri, 28 Nov 2025 14:00:00 GMT</pubDate>
<description>ORLANDO, FL / ACCESS Newswire / November 28, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Myriad Uranium Corp. (OCTQB:MYRUF) on the RedChip Small Stocks, Big Money™show, a sponsored program on Bloomberg TV ...</description>
</item>
<item>
<title>BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-publishes-whitepaper-ai-140000678</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-publishes-whitepaper-ai-140000678</guid>
<pubDate>Tue, 18 Nov 2025 14:00:00 GMT</pubDate>
<description>New publication details how BullFrog Data Networks® and bfLEAP® technology address fundamental AI challenges in drug discovery and developmentGAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the publication of a new whitep</description>
</item>
<item>
<title>BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-present-bfprep-ai-130000314</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-present-bfprep-ai-130000314</guid>
<pubDate>Wed, 12 Nov 2025 13:00:00 GMT</pubDate>
<description>Technical insights session to highlight human-in-the-loop AI agent workflows in drug developmentGAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it will present a technical talk at the upcoming AI Drug Discovery & Dev</description>
</item>
<item>
<title>BullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers Symposium</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-abstract-accepted-130000004</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-announces-abstract-accepted-130000004</guid>
<pubDate>Tue, 04 Nov 2025 13:00:00 GMT</pubDate>
<description>AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals, provides further validation of BullFrog AI’s technology GAITHERSBURG, Md., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enabl</description>
</item>
<item>
<title>Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/join-bullfrog-ai-exclusive-live-120000725</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/join-bullfrog-ai-exclusive-live-120000725</guid>
<pubDate>Thu, 30 Oct 2025 12:00:00 GMT</pubDate>
<description>GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on October 30, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature BullFrog AI’s founder and CEO, Vin Singh. At</description>
</item>
<item>
<title>BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-and-bimergen-energy-interviews-to-air-on-the-redchip-small-stocks-big-moneytm-show-on-bloomberg-tv</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-and-bimergen-energy-interviews-to-air-on-the-redchip-small-stocks-big-moneytm-show-on-bloomberg-tv</guid>
<pubDate>Fri, 24 Oct 2025 13:00:00 GMT</pubDate>
<description>ORLANDO, FLORIDA / ACCESS Newswire / October 24, 2025 / RedChip Companies will air interviews with BullFrog AI, Inc. (Nasdaq:BFRG) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...</description>
</item>
<item>
<title>BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-expands-sales-marketing-120000185</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-expands-sales-marketing-120000185</guid>
<pubDate>Tue, 30 Sep 2025 12:00:00 GMT</pubDate>
<description>GAITHERSBURG, Md., Sept. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the expansion of its internal sales organization to support accelerated commercialization of the Company’s clinical trial optimization offerings, including its recently lau</description>
</item>
<item>
<title>BullFrog AI and Sygnature Discovery Announce Official Sales Launch of BullFrog Data Networks™ to Global Biopharma Clients</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-sygnature-discovery-announce-120000989</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-sygnature-discovery-announce-120000989</guid>
<pubDate>Thu, 25 Sep 2025 12:00:00 GMT</pubDate>
<description>Sales launch marks pivotal commercial milestone, unlocking up to $30 million in potential revenue through 2028GAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its collaboration with Sygnature Discovery, a leading con</description>
</item>
<item>
<title>BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-showcase-ai-powered-120000369</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-showcase-ai-powered-120000369</guid>
<pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate>
<description>GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, that its Director of AI, Machine Learning & Innovation, Juan Felipe Beltrán Lacouture, PhD, will present a live webinar hosted by Xtalks titled “Clinical Data Analysis with Agents: Reliabl</description>
</item>
<item>
<title>BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration</title>
<link>https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-bfprep-bfleap-platforms-120000926</link>
<guid isPermaLink="true">https://6ix.com/company/bullfrog-ai-holdings-inc-common-stock/news/bullfrog-ai-bfprep-bfleap-platforms-120000926</guid>
<pubDate>Mon, 08 Sep 2025 12:00:00 GMT</pubDate>
<description>Joint oncology conference submission planned and follow-on contract discussion underway Validates BullFrog AI’s enterprise-grade platform strategy, combining automation and human-in-the-loop oversight for scalable, trustworthy analytics GAITHERSBURG, Md., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successf</description>
</item>
</channel>
</rss>